We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+12.67%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$75.5B
AUM Growth
+$5.88B
Cap. Flow
-$2.02B
Cap. Flow %
-2.67%
Top 10 Hldgs %
17.51%
Holding
766
New
63
Increased
305
Reduced
293
Closed
88

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.01B
2
MPC icon
Marathon Petroleum
MPC
+$622M
3
CMI icon
Cummins
CMI
+$431M
4
HPQ icon
HP
HPQ
+$410M
5
BA icon
Boeing
BA
+$376M

Sector Composition

Rank Sector Weight
1 Financials 24.21%
2 Healthcare 14.12%
3 Industrials 13.89%
4 Technology 11.57%
5 Energy 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
26
Oracle
ORCL
$331B
$703M 0.93%
13,088,162
+626,663
+5% +$31.9M
NTR icon
27
Nutrien
NTR
$32.7B
$664M 0.88%
12,584,872
+3,556,556
+39% +$185M
DXC icon
28
DXC Technology
DXC
$1.63B
$637M 0.84%
9,911,245
+292,941
+3% +$18.7M
NVS icon
29
Novartis
NVS
$295B
$621M 0.82%
7,212,047
-652,175
-8% -$52.4M
EBAY icon
30
eBay
EBAY
$48.6B
$613M 0.81%
16,515,786
+7,015,365
+74% +$243M
RDS.A
31
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$605M 0.8%
9,661,326
+377,415
+4% +$23.3M
SLG icon
32
SL Green Realty
SLG
$3.88B
$573M 0.76%
6,585,947
+60,057
+0.9% +$5.2M
MCK icon
33
McKesson
MCK
$98.5B
$558M 0.74%
4,763,163
-585,875
-11% -$72.3M
EG icon
34
Everest Group
EG
$15.2B
$557M 0.74%
2,577,488
+120,615
+5% +$26.3M
CVS icon
35
CVS Health
CVS
$137B
$554M 0.73%
10,265,047
-2,117,690
-17% -$131M
PXD
36
DELISTED
Pioneer Natural Resource Co.
PXD
$548M 0.73%
3,596,532
+804,760
+29% +$114M
NBL
37
DELISTED
Noble Energy, Inc.
NBL
$548M 0.73%
22,144,841
+7,725,241
+54% +$175M
LOW icon
38
Lowe's Companies
LOW
$116B
$536M 0.71%
4,900,149
+826,414
+20% +$82.5M
ELV icon
39
Elevance Health
ELV
$81.9B
$522M 0.69%
1,819,947
-849,988
-32% -$246M
LUV icon
40
Southwest Airlines
LUV
$22.1B
$519M 0.69%
9,998,417
+1,219,028
+14% +$64.3M
Y
41
DELISTED
Alleghany Corp
Y
$517M 0.69%
844,685
-57,516
-6% -$35.9M
CCEP icon
42
Coca-Cola Europacific Partners
CCEP
$46.5B
$503M 0.67%
9,717,385
-782,944
-7% -$37.2M
FMC icon
43
FMC
FMC
$1.42B
$498M 0.66%
6,486,738
-165,220
-2% -$12.1M
UNP icon
44
Union Pacific
UNP
$183B
$497M 0.66%
2,973,712
+524,537
+21% +$84.4M
XEC
45
DELISTED
CIMAREX ENERGY CO
XEC
$489M 0.65%
6,989,669
+1,169,027
+20% +$84.1M
MOS icon
46
The Mosaic Company
MOS
$7.09B
$471M 0.62%
17,250,762
+3,007,121
+21% +$91.7M
HPQ icon
47
HP
HPQ
$23.5B
$468M 0.62%
24,061,866
-19,342,969
-45% -$410M
COP icon
48
ConocoPhillips
COP
$147B
$465M 0.62%
6,963,606
+236,305
+4% +$15.9M
KEY icon
49
KeyCorp
KEY
$24.3B
$450M 0.6%
28,580,685
-12,663,365
-31% -$211M
HPE icon
50
Hewlett Packard
HPE
$63.2B
$446M 0.59%
28,872,991
+19,172,670
+198% +$295M

Similar funds

Boston Partners's Q1 2019 Portfolio in Review

As of Q1 2019, Boston Partners held 766 positions worth $75.5B, up 8.5% from $69.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners's Q1 2019 filing shows 63 new, 305 increased, 293 reduced and 88 closed positions. Its largest new stake was Mondelez International: 7,120,191 shares worth $355M. The largest sale was JPMorgan Chase, an estimated $1.01B.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Partners's largest Q1 2019 buy was Mondelez International: 7,120,191 shares worth $355M.
  • Boston Partners added most to DuPont de Nemours in Q1 2019, an estimated $780M increase.
  • Boston Partners's biggest Q1 2019 reduction was JPMorgan Chase, cutting an estimated $1.01B.
  • Boston Partners fully exited Dun & Bradstreet in Q1 2019, selling an estimated $163M.
  • Boston Partners's ten largest holdings make up 18% of its $75.5B portfolio in Q1 2019.
  • Boston Partners opened 63 new positions and closed 88 in Q1 2019.
  • Boston Partners's portfolio value rose 8.5% quarter-over-quarter to $75.5B.

Based on Boston Partners's 13F filing for Q1 2019, filed 3 May 2019.